Moderna's mRNA Technology Is Showing Promise Beyond COVID-19

Moderna's mRNA technology has gained rapid validation as sales of its COVID-19 vaccine soared in 2021, but we think the firm has yet to secure a narrow economic moat around its business, largely ... Read More

COVID: Moderna sues Pfizer, BioNTech for using its mRNA technology

Moderna is suing fellow vaccine developers Pfizer and its German partner BioNTech, accusing it of infringing on patents related to mRNA technology used in their COVID-19 vaccine, the company ... Read More

Moderna sues Pfizer over patents behind COVID-19 vaccine - Los Angeles ...

Moderna said it started developing its mRNA technology platform in 2010, and that helped the company quickly produce its COVID-19 vaccine after the pandemic arrived in early 2020. Science & Medicine ... Read More

Moderna sues Pfizer and BioNTech over COVID-19 vaccine

Moderna is taking Pfizer and Germany's BioNTech to court, claiming the rival drugmakers copied its technology in developing their COVID-19 vaccine. In documents filed in U.S. District Court in ... Read More

Moderna Hit With Another Lawsuit Related To Key COVID-19 Vaccine Technology

Moderna’s COVID-19 vaccines have generated significant profits, capturing 45% of the U.S. COVID-19 vaccine market. In 2021, Moderna earned $5.4 billion in U.S. revenues from its vaccines ... Read More

Moderna's new COVID-19 vaccine mNexspike approved by FDA, but there's a ...

Experts warn about risks of new COVID-19 vaccine guidelines 04:32. The U.S. approved a new COVID-19 vaccine made by Moderna late Friday but with limits on who can use it — not a replacement for ... Read More

Moderna, Inc. (MRNA) Submits Updated COVID Vaccine for Regulatory Review

Moderna, Inc. (NASDAQ:MRNA) announced on Friday that it has submitted a marketing application to the U.S. Food and Drug Administration (FDA) for review of its updated COVID-19 vaccine. The revised ... Read More

FDA approves a next-generation Covid vaccine from Moderna, with ...

The FDA has approved Moderna’s new Covid-19 vaccine, though it placed restrictions on its use that the company’s existing Covid shot does not currently face. Read More

Moderna study shows immune response for a combo flu and COVID-19 shot

A combination shot for flu and COVID-19 using messenger RNA generated antibodies in a company-funded study. The study was published Wednesday in the Journal of the American Medical Association. Read More

FDA grants limited approval to new Covid vaccine from Moderna

Moderna announced this weekend that the Food and Drug Administration approved its lower-dose Covid-19 vaccine for adults 65 and older, as well as people ages 12 to 64 with at least one medical ... Read More

FDA approves Moderna's new lower-dose COVID-19 vaccine - Boston.com

The U.S. approved a new COVID-19 vaccine made by Moderna late Friday but with limits on who can use it — not a replacement for the company’s existing shot, but a second opti Skip to Main Content ... Read More